AbbVie stock rises as insurers crater and the Fed week kicks off
AbbVie shares rose 1.5% to $224.12 Tuesday, peaking at $226.83 as drugmakers outperformed health insurers. UnitedHealth plunged 20%, Humana fell 19%, and CVS dropped 14% after a proposed 0.09% Medicare Advantage rate hike. The S&P 500 hit a new high ahead of the Fed’s meeting. Investors await AbbVie’s Feb. 4 earnings for 2026 guidance.